Nikita Shah's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 366,972 Class A Common Stock done . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 366,972 | 565,742 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 366,972 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 03 Mar 2026 | 183,853 | 381,889 (0%) | 0% | 13.3 | 2,447,083 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 45,871 | 210,004 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 45,871 | 45,872 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 36,232 | 182,635 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 36,232 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 35,880 | 417,769 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 35,880 | 71,760 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 23,544 | 210,566 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 23,544 | 70,634 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 03 Mar 2026 | 22,982 | 187,022 (0%) | 0% | 13.3 | 305,890 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 03 Mar 2026 | 18,502 | 164,133 (0%) | 0% | 13.3 | 246,262 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. | 03 Mar 2026 | 17,976 | 399,793 (0%) | 0% | 13.3 | 239,081 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 03 Mar 2026 | 11,796 | 198,770 (0%) | 0% | 13.3 | 157,005 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 65,359 | 65,359 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 65,359 | 65,359 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 11.92 per share. | 12 Nov 2025 | 131,856 | 146,403 (0%) | 0% | 11.9 | 1,571,724 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 95,525 | 0 | - | - | Stock Option (Right to Buy) | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. | 12 Nov 2025 | 95,525 | 278,259 (0%) | 0% | 2.8 | 262,694 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2025 | 36,331 | 0 | - | - | Stock Option (Right to Buy) | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. | 12 Nov 2025 | 36,331 | 182,734 (0%) | 0% | 2.7 | 99,910 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 9.66 per share. | 22 Aug 2025 | 114,492 | 152,743 (0%) | 0% | 9.7 | 1,105,993 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 22 Aug 2025 | 6,340 | 146,403 (0%) | 0% | 9.5 | 60,230 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 9.29 per share. | 14 Aug 2025 | 71,694 | 267,235 (0%) | 0% | 9.3 | 666,037 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 9.04 per share. | 12 Aug 2025 | 50,000 | 338,929 (0%) | 0% | 9.0 | 452,000 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 16 May 2025 | 49,140 | 388,929 (0%) | 0% | 7.6 | 372,481 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 188,356 | 188,356 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 144,928 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 144,928 | 494,674 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 94,178 | 94,178 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 74,131 | 420,543 (0%) | 0% | 8.8 | 649,388 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 45,872 | 91,743 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 45,872 | 373,210 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 36,232 | 36,232 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 36,232 | 345,871 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 35,879 | 456,422 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 35,879 | 107,640 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 23,464 | 349,746 (0%) | 0% | 8.8 | 205,545 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 18,533 | 327,338 (0%) | 0% | 8.8 | 162,349 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.84 per share. | 03 Mar 2025 | 18,353 | 438,069 (0%) | 0% | 8.8 | 162,241 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 28,958 | 320,624 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 28,958 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.67 per share. | 01 Mar 2025 | 10,985 | 309,639 (0%) | 0% | 8.7 | 95,240 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 7.75 per share. | 14 Aug 2024 | 100,000 | 291,666 (0%) | 0% | 7.8 | 775,000 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 287,038 | 287,038 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 143,519 | 143,519 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 45,871 | 137,615 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 45,871 | 414,648 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 36,232 | 72,464 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 36,232 | 386,930 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 28,957 | 365,879 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 28,957 | 28,958 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.47 per share. | 01 Mar 2024 | 22,982 | 391,666 (0%) | 0% | 5.5 | 125,712 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.47 per share. | 01 Mar 2024 | 18,153 | 368,777 (0%) | 0% | 5.5 | 99,297 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.47 per share. | 01 Mar 2024 | 15,181 | 350,698 (0%) | 0% | 5.5 | 83,040 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 35,620 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 35,620 | 355,592 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.71 per share. | 27 Feb 2024 | 18,670 | 336,922 (0%) | 0% | 5.7 | 106,606 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 366,972 | 366,972 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 183,486 | 183,486 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 36,232 | 338,036 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 36,232 | 108,696 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 03 Mar 2023 | 18,064 | 319,972 (0%) | 0% | 1.9 | 34,683 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 28,958 | 317,359 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 28,958 | 57,915 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 01 Mar 2023 | 15,555 | 301,804 (0%) | 0% | 2.1 | 32,510 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 11,729 | 294,905 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 11,729 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 01 Mar 2023 | 6,504 | 288,401 (0%) | 0% | 2.1 | 13,593 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 35,620 | 302,928 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 35,620 | 35,620 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.16 per share. | 27 Feb 2023 | 19,752 | 283,176 (0%) | 0% | 2.2 | 42,664 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 4,442 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 4,442 | 269,536 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 07 May 2022 | 2,228 | 267,308 (0%) | 0% | 3.4 | 7,575 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 289,856 | 289,856 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 144,928 | 144,928 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 28,957 | 86,873 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 28,957 | 273,999 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 11,728 | 11,729 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 11,728 | 248,649 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.45 per share. | 01 Mar 2022 | 8,905 | 265,094 (0%) | 0% | 4.4 | 39,627 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.45 per share. | 01 Mar 2022 | 3,607 | 245,042 (0%) | 0% | 4.4 | 16,051 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2022 | 35,620 | 71,240 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2022 | 35,620 | 248,616 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. | 27 Feb 2022 | 11,695 | 236,921 (0%) | 0% | 4.6 | 53,680 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 3.95 per share. | 15 Dec 2021 | 2,000 | 212,996 (0%) | 0% | 4.0 | 7,900 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 4,441 | 4,442 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 4,441 | 216,362 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.20 per share. | 07 May 2021 | 1,366 | 214,996 (0%) | 0% | 5.2 | 7,103 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.75 per share. | 15 Mar 2021 | 36,330 | 248,251 (0%) | 0% | 2.8 | 99,908 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 36,330 | 36,331 | - | - | Stock Option (Right to Buy) | |
| Amneal Pharma Inc (Class A) | Nikita Shah | Executive Vice President | Sale of securities on an exchange or to another person at price $ 6.87 per share. | 15 Mar 2021 | 36,330 | 211,921 (0%) | 0% | 6.9 | 249,489 | Class A Common Stock |